IP Library Granted Patent US 9,031,295
Granted Patent B2
US 9,031,295 · App. 13/963,265 · Granted May 12, 2015

Angiographic method for examining a vascular system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,031,295
App. No.
13/963,265
Granted
May 12, 2015
Kind
B2
Abstract

An angiographic method is provided. The method includes: identification of a relevant part in acquired angiography 4D sequences which exhibit a vascular disorder or change; determination of a centerline for the part; ascertainment of lines parallel and surrounding the centerline; specification of perpendicular cross-sections; determination of voxels; ascertainment of bolus curves as a function of time for each voxel; which intersects one of the cross-sections; determination of a time for each voxel; measurement of the true Euclidean distance between voxels at the positions along the centerline and the parallel lines; division of the measured distance by the time difference; determination of second speed components, running transversely, proportional to the relative change in mass for each voxel; and calculation of the blood flow in the relevant part of the vascular system on the basis of the speed components.

Claims (127)

1. An angiographic method for examining a vascular system of an object under examination in order to determine flow characteristics inside vessels, comprising:

S 1 ) acquiring 4D angiography sequences;

S 2 ) identifying a relevant part of the vascular system in the 4D angiography sequences which could exhibit a vascular disorder or vascular change;

S 3 ) determining a centerline for the identified relevant part;

S 4 ) ascertaining of parallel lines which run parallel to the centerline and surround the centerline;

S 5 ) specifying perpendicular cross-sections at least at positions which can be determined or chosen along the centerline;

S 6 ) determining voxels lying on the perpendicular cross-sections;

S 7 ) ascertaining bolus curves as a function of time for each voxel which intersects one of the cross-sections;

S 8 ) determining a time for each of said voxels;

S 9 ) measuring of the true Euclidean distance between voxels at the positions along the centerline and the parallel lines;

S 10 ) dividing said measured distance by the time difference in order to obtain the amplitude of a first speed component of the blood flow speed in each of said voxels;

S 11 ) determining second speed components, running transversely, proportional to the relative change in mass of the blood in the voxels, for each of said voxels and

S 12 ) calculation of the blood flow in the relevant part of the vascular system on the basis of the speed components.

2. The angiographic examination method as claimed in claim 1 ,

wherein the acquisition of the 4D angiography sequences takes place in accordance with step S 1 ) from rotational angiography projections which are superimposed by means of perspective back projection in a static 3D image of the vascular tree.

3. The angiographic examination method as claimed in claim 1 ,

wherein the calculation of the second speed components, running transversely occurs in accordance with S 11 ) according to the formula:

v

(

i

,

k

)

trans

m

(

i

+

1

,

k

+

)

-

m

(

i

,

k

+

)

m

(

i

,

k

)

-

m

(

i

+

1

,

k

)

.

4. The angiographic examination method as claimed in claim 2 ,

wherein the calculation of the second speed components, running transversely occurs in accordance with S 11 ) according to the formula:

v

(

i

,

k

)

trans

m

(

i

+

1

,

k

+

)

-

m

(

i

,

k

+

)

m

(

i

,

k

)

-

m

(

i

+

1

,

k

)

.

5. The angiographic examination method as claimed in claim 1 ,

wherein accordance with S 8 ) the time is the maximum time, rise time of the wash-in phase and/or fall time of the wash-out phase of the bolus curve.

6. The angiographic examination method as claimed in claim 2 ,

wherein accordance with S 8 ) the time is the maximum time, rise time of the wash-in phase and/or fall time of the wash-out phase of the bolus curve.

7. The angiographic examination method as claimed in claim 3 ,

wherein accordance with S 8 ) the time is the maximum time, rise time of the wash-in phase and/or fall time of the wash-out phase of the bolus curve.

8. The angiographic examination method as claimed in claim 1 ,

wherein after calculation of the first speed component for each voxel in accordance with S 10 ) all adjacent voxels are examined as to whether relative changes exist in the masses m(i+1, k+) to m(i, k+), and only then is the transversely running speed component, which exhibits a value proportional to the relative change in mass, determined in order to determine second speed components in accordance with S 11 ) for a voxel.

9. The angiographic examination method as claimed in claim 2 ,

wherein after calculation of the first speed component for each voxel in accordance with S 10 ) all adjacent voxels are examined as to whether relative changes exist in the masses m(i+1, k+) to m(i, k+), and only then is the transversely running speed component , which exhibits a value proportional to the relative change in mass, determined in order to determine second speed components in accordance with S 11 ) for a voxel.

10. The angiographic examination method as claimed in claim 3 ,

wherein after calculation of the first speed component for each voxel in accordance with S 10 ) all adjacent voxels are examined as to whether relative changes exist in the masses m(i+1, k+) to m(i, k+), and only then is the transversely running speed component , which exhibits a value proportional to the relative change in mass, determined in order to determine second speed components in accordance with S 11 ) for a voxel.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2016
From: SIEMENS AKTIENGESELLSCHAFT
To: SIEMENS HEALTHCARE GMBH
Reel/Frame 039271/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2013
From: KLINGENBECK, KLAUS
To: SIEMENS AKTIENGESELLSCHAFT
Reel/Frame 031048/0871 →